Research programme: retinal disorders gene therapies - Kriya Therapeutics
Latest Information Update: 24 Oct 2023
At a glance
- Originator Kriya Therapeutics
- Class Eye disorder therapies; Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Retinal disorders